OOIR: Observatory of International Research

Papers

(The H4-Index of Medicine is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Students’ perception of online learning during the COVID-19 pandemic	302
Association of elevated inflammatory markers and severe COVID-19	133
Inspiratory muscle training for recovered COVID-19 patients after weaning from mechanical ventilation	86
Use of Delphi in health sciences research: A narrative review	70
Omicron SARS-CoV-2 variant of concern	63
Prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic	58
Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment	56
Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome	53
Social support, resilience, and self-esteem protect against common mental health problems in early adolescence	52
International Classification of Diseases, Tenth Revision, Clinical Modification social determinants of health codes are poorly used in electronic health records	49
Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19	47
Comorbidities’ potential impacts on severe and non-severe patients with COVID-19	47
Liuzijue is a promising exercise option for rehabilitating discharged COVID-19 patients	45
Prognostic value of the systemic inflammation response index in human malignancy	44
Manual lymphatic drainage for lymphedema in patients after breast cancer surgery	43
Outcome of bone–patellar tendon–bone vs hamstring tendon autograft for anterior cruciate ligament reconstruction	40
Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient	40
The prognostic value of the SOFA score in patients with COVID-19	40
A review on the evolution of simulation-based training to help build a safer future	40
Anti-IL6 treatment of serious COVID-19 disease	39
Risk factors of cerebral small vessel disease	39
Corticosteroid therapy for COVID-19	38
Clinical, laboratory, and imaging features of pediatric COVID-19	37
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis (“ProDERM Study”)	37
Application of machine learning in CT images and X-rays of COVID-19 pneumonia	36

Association between spiritual well-being, quality of life, anxiety and depression in patients with gynaecological cancer in China	36
AFP-L3 for the diagnosis of early hepatocellular carcinoma	36
Effects of progressive muscle relaxation training on negative emotions and sleep quality in COVID-19 patients	36
HIV infection and risk of COVID-19 mortality	36
Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection	35
COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis	35
Ethical implications of AI and robotics in healthcare: A review	34
Automatic quality assessment for 2D fetal sonographic standard plane based on multitask learning	34
Barriers to using personal protective equipment by healthcare staff during the COVID-19 outbreak in China	34
First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients	34
Molecular genetics of β-thalassemia	34